Condition
Juvenile Chronic Arthritis
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
P 2 (1)
P 4 (1)
Trial Status
Completed1
Not Yet Recruiting1
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT06895278Not Yet RecruitingPrimary
Articular Damage in Patients With Juvenile Idiopathic Arthritis After Transition to Adult Care
NCT06763783Phase 4Enrolling By Invitation
Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases
NCT00037648Phase 2CompletedPrimary
Juvenile Rheumatoid Arthritis
Showing all 3 trials